Alzheimer's disease & dementia
Study examines immunotherapy and cerebrospinal fluid biomarkers in patients with Alzheimer's disease
Immunotherapy with the antibody bapineuzumab in patients with mild to moderate Alzheimer disease resulted in decreases in a cerebrospinal fluid biomarker, which may indicate downstream effects on the degenerative process, ...
Apr 2, 2012
0
0